Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of
• ?30 kg/m2 (obesity), or
• ?27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbidity.
A
Show More
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of
• ?30 kg/m2 (obesity), or
• ?27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbidity.
Adolescents (?12 years)
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adolescents ages 12 years and above with
• obesity* and
• body weight above 60 kg.
Treatment with Wegovy should be discontinued and re-evaluated if adolescent patients have not reduced their BMI by at least 5% after 12 weeks on the 2.4 mg or maximum tolerated dose.
*Obesity (BMI ?95th percentile) as defined on sex- and age-specific BMI growth charts (CDC.gov) (see Table 1).
Less
| Shipping Option |
|---|
| Next Working Day - Monday - Friday (order cut off point 01:00 PM) |
| Saturday (order cut off point 01:00 PM) |
| Select Product | Product Image | Product Name | Product Price |
|---|
Fast selling products from trusted sellers
Quickly buy again your favorite products
Haven’t downloaded the faces app yet? You can download and manage your all your client information and stock directly via your phone or tablet. Purchase stock and submit your e-prescriptions as well as complete consent forms and manage client booking.
My Orders
Need Help?
Technical difficulties
Finance
Pharmacy Orders
General Enquiries
Prescription Services
Calendar and Booking System
Importing clients
